OR WAIT 15 SECS
Julian Upton is Pharmaceutical Executive's Online and European Editor. He can be reached at firstname.lastname@example.org
May 11, 2015.
PaxVax, Inc. (Redwood City, CA), a specialty vaccine company focused on travel and biodefense, has appointed Nima Farzan Chief Executive Officer and President.
In 2013, as PaxVax's then Executive Vice President and Chief Operating Officer, Farzan was featured as one of Pharm Exec's Emerging Pharma Leaders. (See his profile here.) He joined PaxVax in September 2011 from Novartis AG, where he had served in pharmaceutical marketing, sales and development in both the U.S. and global positions. Prior to Novartis, Mr. Farzan worked in marketing and business development at DoubleTwist, Inc., a genomics company, and before that at The Boston Consulting Group.